MicroRNA367 negatively regulates the inflammatory response of microglia by targeting IRAK4 in intracerebral hemorrhage

Journal of Neuroinflammation

Volumn 12, Issue 1, 2015, Pages

  Yuan, Bangqing ^b   Shen, Hanchao ^b   Lin, Li ^b   Su, Tonggang ^b   Zhong, Lina ^a   Yang, Zhao ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b The 476th Hospital of PLA   (China)

Author keywords

ICH; Inflammation; IRAK4; Microglia; MicroRNA367

Indexed keywords

INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MICRORNA; MICRORNA 367; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRAK4 PROTEIN, RAT; MIRN367 MICRORNA, RAT; PROTEIN SERINE THREONINE KINASE;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN EDEMA; BRAIN HEMORRHAGE; CELL ACTIVATION; CELL LYSATE; CONTROLLED STUDY; ERYTHROCYTE; GENE EXPRESSION REGULATION; GENE TARGETING; IN VIVO STUDY; IRAK4 GENE; MEDIATOR RELEASE; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEUROMODULATION; NEWBORN; NF KAPPAB P65 GENE; NONHUMAN; PROTEIN EXPRESSION; RAT; ANIMAL; BODY WATER; BRAIN CHEMISTRY; DRUG EFFECTS; GENE SILENCING; INFLAMMATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; PATHOLOGY; PRIMARY CELL CULTURE; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; BODY WATER; BRAIN CHEMISTRY; BRAIN EDEMA; ERYTHROCYTES; GENE KNOCKDOWN TECHNIQUES; INFLAMMATION; INFLAMMATION MEDIATORS; INJECTIONS, INTRAVENTRICULAR; MICROGLIA; MICRORNAS; NF-KAPPA B; PRIMARY CELL CULTURE; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

EID: 84946563853     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/s12974-015-0424-3     Document Type: Article

References (41)

1. Psaila B, Petrovic A, Page LK, Menell J, Schonholz M, Bussel JB. Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases. Blood. 2009;114:4777-83.
2. Fernandes H, Gregson BA, Siddique MS, Mendelow AD. Testing the ICH score. Stroke. 2002;33:1455-6. author reply -6.
3. Fernandes HM, Siddique S, Banister K, Chambers I, Wooldridge T, Gregson B, et al. Continuous monitoring of ICP and CPP following ICH and its relationship to clinical, radiological and surgical parameters. Acta Neurochir Suppl. 2000;76:463-6.
4. Chen HS, Hsieh CF, Chau TT, Yang CD, Chen YW. Risk factors of in-hospital mortality of intracerebral hemorrhage and comparison of ICH scores in a Taiwanese population. Eur Neurol. 2011;66:59-63.
5. Sato S, Koga M, Yamagami H, Okuda S, Okada Y, Kimura K, et al. Conjugate eye deviation in acute intracerebral hemorrhage: stroke acute management with urgent risk-factor assessment and improvement-ICH (SAMURAI-ICH) study. Stroke. 2012;43:2898-903.
6. Godoy DA, Boccio A. ICH score in a rural village in the Republic of Argentina. Stroke. 2003;34:e150-1. author reply e-1.
7. Aronowski J, Zhao X. Molecular pathophysiology of cerebral hemorrhage: secondary brain injury. Stroke. 2011;42:1781-6.
8. Thiex R. Future perspectives on the fibrinolytic therapy of intracerebral hemorrhages. Cent Nerv Syst Agents Med Chem. 2011;11:150-6.
9. Di Napoli M, Godoy DA, Campi V, del Valle M, Pinero G, Mirofsky M, et al. C-reactive protein level measurement improves mortality prediction when added to the spontaneous intracerebral hemorrhage score. Stroke. 2011;42:1230-6.
10. Loiarro M, Ruggiero V, Sette C. Targeting TLR/IL-1R signalling in human diseases. Mediators Inflamm. 2010;2010:674363.
11. Hubbard LL, Moore BB. IRAK-M regulation and function in host defense and immune homeostasis. Infect Dis Rep. 2010;2:e9.
12. Noris M, Cassis P, Azzollini N, Cavinato R, Cugini D, Casiraghi F, et al. The Toll-IL-1R member Tir8/SIGIRR negatively regulates adaptive immunity against kidney grafts. J Immunol. 2009;183:4249-60.
13. Heinz LX, Rebsamen M, Rossi DC, Staehli F, Schroder K, Quadroni M, et al. The death domain-containing protein Unc5CL is a novel MyD88-independent activator of the pro-inflammatory IRAK signaling cascade. Cell Death Differ. 2012;19:722-31.
14. Chiang EY, Yu X, Grogan JL. Immune complex-mediated cell activation from systemic lupus erythematosus and rheumatoid arthritis patients elaborate different requirements for IRAK1/4 kinase activity across human cell types. J Immunol. 2011;186:1279-88.
15. Lin SC, Lo YC, Wu H. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature. 2010;465:885-90.
16. Lu LF, Gasteiger G, Yu IS, Chaudhry A, Hsin JP, Lu Y, et al. A single miRNA-mRNA interaction affects the immune response in a context- and cell-type-specific manner. Immunity. 2015;43:52-64.
17. Benderska N, Dittrich AL, Knaup S, Rau TT, Neufert C, Wach S, et al. miRNA-26b overexpression in ulcerative colitis-associated carcinogenesis. Inflamm Bowel Dis. 2015;21(9):2039-51.
18. Zeng FR, Tang LJ, He Y, Garcia RC. An update on the role of miRNA-155 in pathogenic microbial infections. Microbes Infect. 2015;17(9):613-21.
19. Oner T, Yenmis G, Tombulturk K, Cam C, Kucuk OS, Yakicier MC, et al. Association of pre-miRNA-499 rs3746444 and pre-miRNA-146a rs2910164 polymorphisms and susceptibility to Behcet's disease. Genet Test Mol Biomarkers. 2015;19:424-30.
20. Dhanasekaran S, Doherty TM, Kenneth J. Comparison of different standards for real-time PCR-based absolute quantification. J Immunol Methods. 2010;354:34-9.
21. Culp WC, Woods SD, Brown AT, Lowery JD, Hennings LJ, Skinner RD, et al. Three variations in rabbit angiographic stroke models. J Neurosci Methods. 2013;212:322-8.
22. Zazulia AR. Hydrocephalus in ICH: what do we really know? Neurocrit Care. 2008;8:233-4.
23. Wartenberg KE, Mayer SA. Reducing the risk of ICH enlargement. J Neurol Sci. 2007;261:99-107.
24. Mitchell P, Gregson BA, Vindlacheruvu RR, Mendelow AD. Surgical options in ICH including decompressive craniectomy. J Neurol Sci. 2007;261:89-98.
25. Leclerc JL, Lampert AS, Diller MA, Immergluck JB, Dore S. Prostaglandin E2 EP2 receptor deletion attenuates intracerebral hemorrhage-induced brain injury and improves functional recovery. ASN Neuro. 2015;7.
26. Hollig A, Weinandy A, Nolte K, Clusmann H, Rossaint R, Coburn M. Experimental subarachnoid hemorrhage in rats: comparison of two endovascular perforation techniques with respect to success rate, confounding pathologies and early hippocampal tissue lesion pattern. PLoS One. 2015;10:e0123398.
27. Urday S, Kimberly WT, Beslow LA, Vortmeyer AO, Selim MH, Rosand J, et al. Targeting secondary injury in intracerebral haemorrhage-perihaematomal oedema. Nat Rev Neurol. 2015;11:111-22.
28. Carstens JL, Lovisa S, Kalluri R. Microenvironment-dependent cues trigger miRNA-regulated feedback loop to facilitate the EMT/MET switch. J Clin Invest. 2014;124:1458-60.
29. Ayyadurai S, Charania MA, Xiao B, Viennois E, Zhang Y, Merlin D. Colonic miRNA expression/secretion, regulated by intestinal epithelial PepT1, plays an important role in cell-to-cell communication during colitis. PLoS One. 2014;9:e87614.
30. Nielsen S, Akerstrom T, Rinnov A, Yfanti C, Scheele C, Pedersen BK, et al. The miRNA plasma signature in response to acute aerobic exercise and endurance training. PLoS One. 2014;9:e87308.
31. Sarma NJ, Tiriveedhi V, Subramanian V, Shenoy S, Crippin JS, Chapman WC, et al. Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway. PLoS One. 2012;7:e50826.
32. Xie W, Li Z, Li M, Xu N, Zhang Y. miR-181a and inflammation: miRNA homeostasis response to inflammatory stimuli in vivo. Biochem Biophys Res Commun. 2013;430:647-52.
33. Chen PY, Qin L, Barnes C, Charisse K, Yi T, Zhang X, et al. FGF regulates TGF-beta signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression. Cell Rep. 2012;2:1684-96.
34. Li X. IRAK4 in TLR/IL-1R signaling: possible clinical applications. Eur J Immunol. 2008;38:614-8.
35. Kim TW, Staschke K, Bulek K, Yao J, Peters K, Oh KH, et al. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J Exp Med. 2007;204:1025-36.
36. Davidson DJ, Currie AJ, Bowdish DM, Brown KL, Rosenberger CM, Ma RC, et al. IRAK-4 mutation (Q293X): rapid detection and characterization of defective post-transcriptional TLR/IL-1R responses in human myeloid and non-myeloid cells. J Immunol. 2006;177:8202-11.
37. Motegi H, Shimo Y, Akiyama T, Inoue J. TRAF6 negatively regulates the Jak1-Erk pathway in interleukin-2 signaling. Genes Cells. 2011;16:179-89.
38. Zhou F, Zhang X, van Dam H, Ten Dijke P, Huang H, Zhang L. Ubiquitin-specific protease 4 mitigates Toll-like/interleukin-1 receptor signaling and regulates innate immune activation. J Biol Chem. 2012;287:11002-10.
39. Rakoff-Nahoum S, Kong Y, Kleinstein SH, Subramanian S, Ahern PP, Gordon JI, et al. Analysis of gene-environment interactions in postnatal development of the mammalian intestine. Proc Natl Acad Sci U S A. 2015;112:1929-36.
40. Zhu Z, Xu Y, Zhao J, Liu Q, Feng W, Fan J, et al. miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-beta signalling pathway. Br J Cancer. 2015;112:1367-75.
41. Kuo CH, Deng JH, Deng Q, Ying SY. A novel role of miR-302/367 in reprogramming. Biochem Biophys Res Commun. 2012;417:11-6.